Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Istituto Dermopatico Dell'Immacolata (IDI-IRCCS), Rome, Italy

European Journal of Cancer Prevention

Volumn 15, Issue 2, 2006, Pages 171-177

  Fortes, Cristina ^a   Mastroeni, Simona ^a   Sera, Francesco ^a   Concolino, Francesco ^a   Abeni, Damiano ^a   Melchi, Franco ^a   Forastiere, Francesco ^b   Pasquini, Paolo ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b ASL RM/E   (Italy)

Author keywords

Cutaneous melanoma; Premature mortality; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR VOLUME; YEARS OF LIFE LOST;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33746630541     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000178077.27748.fb     Document Type: Article

References (30)

1. Balch C, Seong SJ, Gershenwald J, et al. (2001). Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on cancer melanoma staging system. J Clin Oncol 19: 3622-3634.
2. Barnhill RL (1995). Pathology of Melanocytic Nevi and Malignant Melanoma. Boston: Butterworth-Heinemann.
3. Barnhill RL, Fine JA, Roush GC, et al. (1996). Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 78: 427-432.
4. Breslow A (1970). Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902-908.
5. Clark WH, From L, Bernardino EA, et al. (1969). The histogenesis and biologic behaviour of primary human malignant melanomas of the skin. Cancer Res 29: 705-727.
6. Clark WH, Elder DE, Guerry D, et al. (1989). Model predicting survival in stage I melanoma based on tumour progression. J Natl Cancer Inst 81: 1893-1904.
7. Cook MG, Spatz A, Brocker EB, Ruiter DJ (2002). Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol 197: 188-193.
8. Corona R, Scio M, Mele A, et al. (1994). Survival and prognostic factors in patients with localised cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell'Immacolata in Rome, Italy. Eur J Cancer 30: 333-338.
9. Fontaine D, Parkhill W, Greer W, Walsh N (2003). Partial regression of primary cutaneous melanoma: is there an association with sub-clinical sentinel lymph node metastasis? Am J Dermatopathol 25: 371-376.
10. Friedman R, Rigel D, Kopf A, et al. (1983). Favourable prognosis for malignant melanomas associated with acquired melanocytic nevi. Arch Dermatol 119: 455-462.
11. Garbe C, Buttner P, Bertz J, et al. (1995). Primary cutaneous melanoma: identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 75: 2484-2491.
12. Heinzerling LM, Dummer R, Panizzon RG, et al. (2002). Prevention campaign against skin cancer. Dermatology 205: 229-233.
13. Kolmel KF, Kulle B, Lippold A, et al. (2002). Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. Eur J Cancer 38: 1388-1394.
14. Mac Kie RM, Aitchison T, Sirel JM, et al. (1995). Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation. Br J Cancer 71: 173-176.
15. Marghood A, Koening K, Bittencourt F, et al. (2000). Breslow thickness and Clark level in melanoma. Cancer 88: 589-595.
16. Masback A, Westerdahl J, Ingvar C, et al. (1997). Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations. Cancer 79: 275-283.
17. Masback A, Olsson H, Westerdahl J, et al. (2001). Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review. Melanoma Res 11: 435-445.
18. Massi D, Borgognoni L, Franchi A, et al. (2000). Thick cutaneous malignant melanoma: a reappraisal of prognostic factors. Melanoma Res 10: 153-164.
19. Morton DL, Hsueh EC, Essner R, et al. (2002). Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes. Ann Surg 236: 438-448.
20. Muller MGS, Leeuwen PA, Lange-de Klerk ESM, et al. (2001). The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 91: 2401-2408.
21. Owen SA, Sanders LL, Edwards LJ, et al. (2001). Identification of higher risk thin melanomas should be based on Breslow deph not Clark level IV. Cancer 91: 983-991.
22. Parkin DM, Bray F, Ferlay J, et al. (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156.
23. Richard MA, Grob JJ, Avril MF, et al. (2000). Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 89: 271-279.
24. Richardson B, Price A, Wagner M, et al. (1999). Investigation of female survival benefit in metastatic melanoma. Br J Cancer 80: 2025-2033.
25. Rossi CR, Vecchiato A, Bezze G, et al. (2000). Early detection of melanoma: an educational campaign in Padova, Italy. Melanoma Res 10: 181-187.
26. Sahin S, Rao B, Kopf AW, et al. (1997). Predicting ten-year survival of patients with primary cutaneous melanoma. Cancer 80: 1426-1431.
27. Spatz A, Shaw HM, Crotty KA, et al. (1998). Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (>5 mm). Histopathology 33: 406-413
28. Thorn M, Ponten F, Bergstrim R, et al. (1994). Clinical and histopathologic predictors of survival in patients with malignant melanoma: a populationbased study in Sweden. J Natl Cancer Inst 86: 761-769.
29. Schmid-Wendtner H, Baumert J, Schmidt M, et al. (2001). Prognostic index for cutaneous melanoma: an analysis after follow-up of 2715 patients. Melanoma Res 11: 619-626.
30. Zettersten E, Sagebiel RW, Miller JR, et al. (2002). Prognostic factors in patients with thick cutaneous melanoma (>4 mm). Cancer 94: 1049-1056.